Stay updated with the latest efficacy news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on efficacy topics.
Hyderabad: CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, on Monday said it has reported positive top-line Phase 3 results for BP11, its investigational biosimilar to Xolair, or omalizumab.CuraTeQ said the study met all primary endpoints in patients with chronic spontaneous urticaria receiving the 300 mg dose, demonstrating high comparability with the reference product. The company said it plans to use the results to support regulatory submissions for chronic spontaneous urtic ...Read More >
Hyderabad, April 6 (RAHNUMA): CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has announced positive top-line results from its Phase 3 trial of BP11, an investigational biosimilar to Omalizumab (marketed as Xolair). The study met all primary endpoints, demonstrating strong comparability with the reference drug in treating chronic spontaneous urticaria (CSU) at a 300 mg dose. Conducted across 608 patients at nearly 80 sites in Europe and India, the trial showed precise equivalence in itch s ...Read More >
Two-year-old Bain Brandon has type 1 diabetes and needs insulin to live. But even with health insurance, the price tag isn't cheap. A 1-month supply of insulin vials and a 3-month supply of backup pens for the Mississippi toddler cost his parents $194 last week, according to his mom, 29-year-old Marlee Brandon. They can afford it right now -- but she worries about the future. "One day, Bain will be an adult, and he won't be able to be on our insurance anymore," she said. "I feel like a lot of ...Read More >
New Delhi, April 4 (SocialNews.XYZ) Union Minister Dr Jitendra Singh met with International Diabetes Federation President-elect Dr Niti Pall, and the latter highlighted that Asian and African countries "are increasingly looking to India for affordable diabetes care solutions," due to leadership in supplying cost-effective vaccines, an official statement said on Saturday. Dr Singh and Dr Pall discussed indigenous biosimilar insulin production and diabetes related indigenous biomanufacturing pros ...Read More >
NEW DELHI, Apr 4 : "International Diabetes Federation" (IDF) President-elect, Dr Niti Pall, currently on India visit, called on Union Minister Dr Jitendra Singh, who is also a noted Professor of Medicine & Diabetes, and discussed, among other things, indigenous biosimilar Insulin production as well as Diabetes related indigenous biomanufacturing prospects. The meeting underscored the importance of strengthening India's capabilities in insulin manufacturing, particularly biosimilar insulins and ...Read More >
KAMA AYURVEDA has launched Sandanya, an anti-blemish skincare collection based on Ayurveda and modern science. It offers blemish-prone skin a balanced care routine with 21 botanicals and modern actives such as botanical salicylic acid. Mahieka Sharma is the brand face, promoting mindful beauty philosophy. KAMA AYURVEDA has unveiled Sandanya, its premiere anti-blemish skincare collection, designed specifically for blemish-prone and imbalanced skin. Rooted in ancient Ayurvedic wisdom and supporte ...Read More >
Qdenga vaccine against dengue (image is for representation purposes only) AI generated image ShowQuick Read Summary is AI-generated, newsroom-reviewed * Qdenga dengue vaccine expected to launch in India by 2026 after regulatory approval * Vaccine developed by Takeda Pharma, to be made in India with Biological E under Make-in-India * Qdenga requires two doses and protects against all dengue serotypes, including prior infections Did our AI summary help? Let us know. Switch To Beeps Mode ...Read More >
A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence aft ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Paduko ...Read More >
New Delhi [India], October 31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases. In a new draft guidance, the FDA has proposed major updates aimed at simplifying biosimilarity studies and reducing unnecessary clinical testing. The agency also launched a separate initiative to make it easier for biosimilars t ...Read More >
New Delhi, Oct 24 (SocialNews.XYZ) The Ministry of Ayush on Friday announced a two-day national seminar to boost liver health through Ayurveda, taking forward its commitment to evidence-based traditional medicine. The national seminar -- Hepatobiliary Wellness through Ayurveda: Bridging Traditional Wisdom with Contemporary Science -- will be organised along with the Indian Council of Medical Research (ICMR), from October 25 to 26 in Odisha's Bhubaneswar. The seminar, themed "Yakrut Suraksha, J ...Read More >
New Delhi [India], October 27: Meyer Vitabiotics, one of India's leading nutraceutical companies, has partnered with Fresh Box Media, an integrated digital marketing agency, to strengthen its overall brand presence across the digital ecosystem. The partnership aims to refresh Meyer Vitabiotics' online strategy with a stronger focus on engagement, visibility, and meaningful communication across audiences. Through this collaboration, Fresh Box Media will work towards reimagining how Meyer Vitabio ...Read More >
Mumbai (Maharashtra) [India], October 24: ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from the Food Safety and Standards Authority of India (FSSAI), which mandates the removal of the term 'ORS' from food and beverage product names, labels, and trademarks, unless they meet the medically approved formulation of an Oral Rehydration Solution as mandated by the World Health Organisation (WHO). Also Read | Real Sociedad vs Sevilla, La Liga 2025-26 Free Live S ...Read More >
New Delhi, Oct 9 (PTI) Drug firm Lupin on Thursday announced the launch of a strategic partnership programme aimed at expanding the reach of a long-acting injectable platform developed by its subsidiary, Nanomi BV. The platform, PrecisionSphere demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent US Food and Drug Administration (USFDA) approval for the first product developed with this platform. The company's partnership programme is designed ...Read More >
MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ - the long-acting injectable (LAI) platform developed by its subsidiary, Nanomi B.V. (Nanomi). PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent Unit ...Read More >
NewsVoir Ahmedabad (Gujarat) [India], September 29: As India observes World Heart Day, the conversation around cardiovascular health has once again turned to prevention, timely treatment, and most importantly, access to affordable medicines for everyone. Heart disease remains the leading cause of death in India at 28.1%, with more than half a billion people affected by a heart ailment. While treatment protocols have advanced, the cost of long-term medication continues to be a burden for many fa ...Read More >
Srinagar -- In what could be a miracle improving and saving thousands of lives across the globe, Russia's mRNA-based vaccine Enteromix has displayed 100% efficacy and safety in early clinical trials. Scientists say the breakthrough could mark a new chapter in the fight against aggressive cancers, offering patients hope where few options exist. For decades, cancer has been one of humanity's most formidable enemies. Conventional treatments like chemotherapy and radiation, while sometimes life-sav ...Read More >
Jammu, Aug 20 (PTI) A free vaccination drive to prevent cancer of the uterine cervix among the girls of Jammu and Kashmir was launched here on Wednesday, an official said. Health Minister Sakeena Itoo inaugurated the first-of-its-kind initiative, reaffirming the government's commitment to saving lives and building a healthy future for women across the region. She emphasised the importance of raising awareness about the Human Papillomavirus (HPV) vaccine and called for a sustained campaign to d ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
New Delhi, Jul 20 (PTI) Star Indian long jumper Murali Sreeshankar clinched the title with a leap of 7.75m at the Meeting Maia Cidade do Desporto in Maia, Portugal, a World Athletics Continental Tour Bronze-level meet. The Asian Games silver medallist registered his best effort in the second round on Saturday night. Sreeshankar opened with a 7.63m jump, followed it up with his winning leap of 7.75m in the second round, and then recorded a solid 7.69m. His third attempt was a foul, while his fi ...Read More >
New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >
New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >
Bhubaneswar: The Indian Council of Medical Research (ICMR), New Delhi, on Thursday invited expressions of interest from eligible organisations, companies, and manufacturers for undertaking the 'transfer of technology' for commercialisation of a malaria vaccine developed by ICMR-Regional Medical Research Centre (RMRC), Bhubaneswar.This technology, "A recombinant chimeric multi-stage malaria vaccine (AdFalciVax) against Plasmodium falciparum", is useful in preventing Plasmodium falciparum infectio ...Read More >
New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >
New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >
Dr. Mujahid Gilani (Senior Kashmiri Leader): Long before 14 August 1947, people of Jammu and Kashmir had voted in favour of Pakistan even before the division of Sub-Continent. They gave their decision over vehemently to become to join Pakistan as its Muslim majority province. In the backdrop of global situation, we must realize that people of Jammu and Kashmir are struggling for maintaining their lives. Their ratio of population in Jammu and Kashmir which was over 98 % in 1947 has been reduced a ...Read More >
FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable Biosimilar to NovoLog BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India: July 15, 2025 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (FDA) has approved Kirsty™ (Insulin Aspart-xjhz), 100 units/mL as the first and only interchangeable* biosimilar to NovoLog® (Insulin ...Read More >
New Delhi: Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 centres in India, according to ICMR scientists. So far, 8,000 participants in various centres at Pune, Chennai, Kolkata, Delhi and Bhubaneswar, among others, have received either the vaccine or a placebo as part of the trial sponsored by the Indian Council of Medical Research (ICMR) and Pana ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.